-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: September 2011
Doggonn It! This Kitty May Be Researchers’ New Best Friend
The glow-in-the-dark cat is out of the bag. Researchers at the Mayo Clinic in Rochester, Minnesota have genetically modified domestic cats to resist the feline form of AIDS. As reported in the journal Nature Methods, this new achievement is a milestone in the ongoing quest to protect humans from the virus. And yes, these kitties glow in the dark. A green fluorescent protein was added to a gene from rhesus macaque monkeys that is known Read More >
BIO Investor Forum Company Snapshot: Syndax Pharmaceuticals
Next up in our Company Snapshot segment for the BIO Investor Forum is another presenting company of the event. Hear from Joanna Horobin, President & CEO of Syndax Pharmaceuticals, Inc. Company Snapshot What are the short-term and long-term priorities for your company? Near-term we are focused on moving our lead product candidate, entinostat, in to a phase 3 clinical trial for post-menopausal women with estrogen receptor-positive (ER+) metastatic breast cancer (MBC). Long-term our goal is Read More >
Bi-partisan Senate Letter asking for 12 years of Data Protection in TPP
Senators Hatch and Kerry, along with 35 other Senators, sent a letter to Ambassador Kirk asking for 12 years of regulatory data protection consistent with U.S. law in the Trans Pacific Partnership Agreement. We are united in urging you to propose a strong minimum term of regulatory data protection for biologics consistent with U.S. law. As you are aware, U.S. law provides for a 12-year term of regulatory data protection for biologics and we believe that should serve Read More >
Registration Now Open for California Healthcare Institute’s Annual Meeting
Register Now for CHI Annual Meeting, Nov. 3, in San Francisco and Save Register now for CHI’s 2011 Annual Meeting, focused on the relationship between biomedical innovation and public policy, and receive early-bird savings to this signature event. The annual meeting, “Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model,” takes place Thursday, Nov. 3, at San Francisco’s Julia Morgan Ballroom. The event will bring together hundreds of leading executives from biotechnology, medical device and Read More >
Blue Angels Fly on Advanced Biofuel Blend
The Navy’s Blue Angels Flight Demonstration Squadron flew on a 50-50 blend of aviation biofuels during the Naval Air Station Patuxent River’s 2011 Air Expo over the Labor Day Weekend. Some inside the Washington Beltway may have thought they were seeing unicorns, but the Blue Angels’ air show and practice runs marked a high profile step in the military’s march toward use of renewable energy. In earlier remarks, Secretary of the Navy Ray Mabus noted Read More >
